Showing 1 - 14 results of 14 for search 'Javier Fernández-Ruiz', query time: 0.07s
Refine Results
-
1
-
2
-
3
Neuroprotection with the Cannabidiol Quinone Derivative VCE-004.8 (EHP-101) against 6-Hydroxydopamine in Cell and Murine Models of Parkinson’s Disease by Sonia Burgaz, Concepción García, María Gómez-Cañas, Alain Rolland, Eduardo Muñoz, Javier Fernández-Ruiz
Published 2021-05-01
Article -
4
-
5
Endocannabinoid System in Spinocerebellar Ataxia Type-3 and Other Autosomal-Dominant Cerebellar Ataxias: Potential Role in Pathogenesis and Expected Relevance as Neuroprotective Ta... by María Gómez-Ruiz, María Gómez-Ruiz, María Gómez-Ruiz, María Gómez-Ruiz, Carmen Rodríguez-Cueto, Carmen Rodríguez-Cueto, Carmen Rodríguez-Cueto, Eva Luna-Piñel, Eva Luna-Piñel, Eva Luna-Piñel, Eva Luna-Piñel, Mariluz Hernández-Gálvez, Mariluz Hernández-Gálvez, Mariluz Hernández-Gálvez, Mariluz Hernández-Gálvez, Javier Fernández-Ruiz, Javier Fernández-Ruiz, Javier Fernández-Ruiz
Published 2019-04-01
Article -
6
-
7
-
8
Beneficial Effect of Dimethyl Fumarate Drug Repositioning in a Mouse Model of TDP-43-Dependent Frontotemporal Dementia by Ignacio Silva-Llanes, Raquel Martín-Baquero, Alicia Berrojo-Armisen, Carmen Rodríguez-Cueto, Javier Fernández-Ruiz, Eva De Lago, Isabel Lastres-Becker
Published 2024-09-01
Article -
9
Investigation in blood-brain barrier integrity and susceptibility to immune cell penetration in a mouse model of Dravet syndrome by Cristina Alonso, Alicia García-Culebras, Valentina Satta, Inés Hernández-Fisac, Álvaro Sierra, José A. Guimaré, Ignacio Lizasoain, Javier Fernández-Ruiz, Onintza Sagredo
Published 2025-03-01
Article -
10
THE EFFICACY OF COMBINED TREATMENT WITH ΒETA-CARYOPHYLLENE AND CANNABIDIOL IN A MOUSE MODEL OF DRAVET SYNDROME by José Antonio Guimaré Ortiz, Valentina Satta, Álvaro Sierra Tarazona, Cristina Alonso Gómez, Ines Hernández-Fisac, Ana Gómez Soria, Onintza Sagredo, Javier Fernández Ruiz
Published 2023-10-01
Article -
11
Preclinical investigation in FAAH inhibition as a neuroprotective therapy for frontotemporal dementia using TDP-43 transgenic male mice by Irene Santos-García, Carmen Rodríguez-Cueto, Patricia Villegas, Fabiana Piscitelli, Anna Lauritano, Che-Kun J. Shen, Vincenzo Di Marzo, Javier Fernández-Ruiz, Eva de Lago
Published 2023-05-01
Article -
12
Investigation in the cannabigerol derivative VCE-003.2 as a disease-modifying agent in a mouse model of experimental synucleinopathy by Sonia Burgaz, Elisa Navarro, Santiago Rodríguez-Carreiro, Carmen Navarrete, Martin Garrido-Rodríguez, Isabel Lastres-Becker, Julia Chocarro, José L. Lanciego, Eduardo Muñoz, Javier Fernández-Ruiz
Published 2024-11-01
Article -
13
Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson’s Disease and Amyotrophic Lateral Sclerosis by Sonia Burgaz, Concepción García, Claudia Gonzalo-Consuegra, Marta Gómez-Almería, Francisco Ruiz-Pino, Juan Diego Unciti, María Gómez-Cañas, Juan Alcalde, Paula Morales, Nadine Jagerovic, Carmen Rodríguez-Cueto, Eva de Lago, Eduardo Muñoz, Javier Fernández-Ruiz
Published 2021-12-01
Article -
14
Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson’s disease: possible involvement of different... by Concepción García, María Gómez-Cañas, Sonia Burgaz, Belén Palomares, Yolanda Gómez-Gálvez, Cristina Palomo-Garo, Sara Campo, Joel Ferrer-Hernández, Carolina Pavicic, Carmen Navarrete, M. Luz Bellido, Moisés García-Arencibia, M. Ruth Pazos, Eduardo Muñoz, Javier Fernández-Ruiz
Published 2018-01-01
Article